FDA preemption language in agency reform bill sought by NDMA.
This article was originally published in The Tan Sheet
Executive Summary
NDMA SEEKS "EXPRESS" LANGUAGE RECOGNIZING FDA REGULATORY PREEMPTION over states in FDA reform legislation with the aim of establishing uniform national requirements. In a March 8 statement to the Senate on Labor and Human Resources Committee, the Nonprescription Drug Manufacturers Association asked that such language be added to Committee Chairman Nancy Kassebaum's (R-Kan.) FDA reform bill (S 1477).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning